<DOC>
	<DOCNO>NCT02105324</DOCNO>
	<brief_summary>This study test hypothesis wearable automate bionic pancreas system automatically deliver insulin glucagon improve glycemic control vs. usual care young people type 1 diabetes age 6-11 year old diabetes camp environment .</brief_summary>
	<brief_title>The Summer Camp Study 2 : Blood Glucose Control With Bi-Hormonal Endocrine Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Inclusion Criteria Age 611 year type 1 diabetes least one year Diabetes manage use insulin infusion pump â‰¥ three month Willing wear two infusion set CGM sensor change set frequently ( least one new glucagon infusion set daily ) Otherwise healthy ( mild chronic disease asthma allow well control require medication result exclusion ) Exclusion Criteria Unable provide inform consent , inform assent parental consent Unable comply study procedure Current participation another diabetesrelated clinical trial , judgment principal investigator , compromise result study safety subject End stage renal disease dialysis ( hemodialysis peritoneal dialysis ) Pregnancy ( positive urine HCG ) History liver disease expect interfere antihypoglycemia action glucagon ( e.g . liver failure cirrhosis ) . Other liver disease ( i.e . active hepatitis , steatosis , active biliary disease , tumor liver , hemochromatosis , glycogen storage disease ) may exclude subject cause significant compromise liver function may unpredictable fashion Personal history cystic fibrosis , pancreatitis , pancreatic disease , include pancreatic tumor insulinoma History prolong QT arrhythmia , congenital heart disease current know cardiac disease Acute illness ( nonvomiting viral illness ) exacerbation chronic illness T1D time study Seizure disorder , history seizure within last two year , ongoing treatment anticonvulsant Untreated inadequately treat mental illness ( indicator would include symptoms psychosis , hallucination , mania , psychiatric hospitalization last year ) , treatment second generation antipsychotic medication , know affect glucose regulation . Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible RF interference Use oral ( e.g . thiazolidinediones , biguanides , sulfonylurea , glitinides , DPP4 inhibitor , SGLT2 inhibitor ) antidiabetic medication History adverse reaction glucagon ( include allergy ) besides nausea vomiting . Unwilling unable completely avoid acetaminophen comparator bionic pancreas arm study History eat disorder anorexia , bulimia , diabulemia omission insulin manipulate weight History intentional , inappropriate administration insulin lead severe hypoglycemia require treatment Any factor , opinion principal investigator , would interfere safe completion study procedure</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>bionic pancreas</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>insulin</keyword>
	<keyword>glucagon</keyword>
	<keyword>continuous glucose monitoring ( CGM )</keyword>
	<keyword>outpatient</keyword>
	<keyword>insulin pump</keyword>
	<keyword>pediatrics</keyword>
	<keyword>child</keyword>
	<keyword>camp</keyword>
	<keyword>summer camp</keyword>
</DOC>